Amoy Diagnostics Co., Ltd. (SHE:300685)
China
· Delayed Price · Currency is CNY 20.51
-0.03 (-0.15%)
Apr 29, 2026, 3:04 PM CST
Amoy Diagnostics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 1,187 | 1,104 | 1,034 | 832.43 | 908.12 | Upgrade
|
| Other Revenue | 10.39 | 4.64 | 9.99 | 9.75 | 8.91 | Upgrade
|
| Revenue | 1,198 | 1,109 | 1,044 | 842.18 | 917.03 | Upgrade
|
| Revenue Growth (YoY) | 8.01% | 6.27% | 23.91% | -8.16% | 25.90% | Upgrade
|
| Cost of Revenue | 219.19 | 181.34 | 176.92 | 153.44 | 147.19 | Upgrade
|
| Gross Profit | 978.54 | 927.61 | 866.58 | 688.74 | 769.84 | Upgrade
|
| Selling, General & Admin | 396.29 | 418.83 | 384.71 | 360.44 | 364.31 | Upgrade
|
| Research & Development | 177.59 | 216.11 | 203.22 | 174.53 | 156.12 | Upgrade
|
| Other Operating Expenses | 11.4 | 4.66 | 4.07 | 3.14 | 4.18 | Upgrade
|
| Operating Expenses | 592.86 | 650.35 | 597.12 | 545.1 | 534.79 | Upgrade
|
| Operating Income | 385.68 | 277.25 | 269.46 | 143.64 | 235.05 | Upgrade
|
| Interest Expense | -1.93 | -1.34 | -1.2 | -0.99 | -0.38 | Upgrade
|
| Interest & Investment Income | 39.76 | 26.58 | 19.17 | 6.11 | 5.59 | Upgrade
|
| Currency Exchange Gain (Loss) | -6.85 | 2.42 | 8.25 | 25.32 | -9.48 | Upgrade
|
| Other Non Operating Income (Expenses) | -19.08 | -18.45 | -0.33 | -2.08 | -0.48 | Upgrade
|
| EBT Excluding Unusual Items | 397.58 | 286.46 | 295.35 | 171.99 | 230.3 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.71 | -8.71 | -15.69 | 1.98 | 5.85 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.49 | -1.06 | -0.96 | 94.58 | -1.96 | Upgrade
|
| Asset Writedown | -2.84 | -0.06 | -0.04 | -0.61 | -0.27 | Upgrade
|
| Other Unusual Items | 14.99 | 13.26 | 16.19 | 18.15 | 18.06 | Upgrade
|
| Pretax Income | 410.92 | 289.88 | 294.86 | 286.08 | 251.98 | Upgrade
|
| Income Tax Expense | 49.67 | 35.02 | 33.37 | 21.79 | 12.95 | Upgrade
|
| Earnings From Continuing Operations | 361.26 | 254.86 | 261.48 | 264.29 | 239.02 | Upgrade
|
| Minority Interest in Earnings | - | - | - | -0.55 | 0.55 | Upgrade
|
| Net Income | 361.26 | 254.86 | 261.48 | 263.74 | 239.57 | Upgrade
|
| Net Income to Common | 361.26 | 254.86 | 261.48 | 263.74 | 239.57 | Upgrade
|
| Net Income Growth | 41.74% | -2.53% | -0.86% | 10.09% | 32.86% | Upgrade
|
| Shares Outstanding (Basic) | 397 | 398 | 396 | 394 | 399 | Upgrade
|
| Shares Outstanding (Diluted) | 401 | 398 | 396 | 394 | 399 | Upgrade
|
| Shares Change (YoY) | 0.80% | 0.51% | 0.65% | -1.41% | -0.36% | Upgrade
|
| EPS (Basic) | 0.91 | 0.64 | 0.66 | 0.67 | 0.60 | Upgrade
|
| EPS (Diluted) | 0.90 | 0.64 | 0.66 | 0.67 | 0.60 | Upgrade
|
| EPS Growth | 40.63% | -3.03% | -1.49% | 11.67% | 33.33% | Upgrade
|
| Free Cash Flow | 294.6 | 301.64 | 253.85 | 70.75 | 93.61 | Upgrade
|
| Free Cash Flow Per Share | 0.73 | 0.76 | 0.64 | 0.18 | 0.23 | Upgrade
|
| Dividend Per Share | 0.450 | 0.300 | 0.150 | 0.140 | 0.128 | Upgrade
|
| Dividend Growth | 50.00% | 100.00% | 7.14% | 9.55% | -7.99% | Upgrade
|
| Gross Margin | 81.70% | 83.65% | 83.05% | 81.78% | 83.95% | Upgrade
|
| Operating Margin | 32.20% | 25.00% | 25.82% | 17.06% | 25.63% | Upgrade
|
| Profit Margin | 30.16% | 22.98% | 25.06% | 31.32% | 26.13% | Upgrade
|
| Free Cash Flow Margin | 24.60% | 27.20% | 24.33% | 8.40% | 10.21% | Upgrade
|
| EBITDA | 429.88 | 329.31 | 322.24 | 191.46 | 271.49 | Upgrade
|
| EBITDA Margin | 35.89% | 29.70% | 30.88% | 22.73% | 29.61% | Upgrade
|
| D&A For EBITDA | 44.2 | 52.05 | 52.78 | 47.82 | 36.45 | Upgrade
|
| EBIT | 385.68 | 277.25 | 269.46 | 143.64 | 235.05 | Upgrade
|
| EBIT Margin | 32.20% | 25.00% | 25.82% | 17.06% | 25.63% | Upgrade
|
| Effective Tax Rate | 12.09% | 12.08% | 11.32% | 7.62% | 5.14% | Upgrade
|
| Revenue as Reported | 1,198 | 1,109 | 1,044 | 842.18 | 917.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.